114 related articles for article (PubMed ID: 14699441)
1. Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution.
Okada M; Northup JK; Ozaki N; Russell JT; Linnoila M; Goldman D
Mol Psychiatry; 2004 Jan; 9(1):55-64. PubMed ID: 14699441
[TBL] [Abstract][Full Text] [Related]
2. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C).
Lappalainen J; Zhang L; Dean M; Oz M; Ozaki N; Yu DH; Virkkunen M; Weight F; Linnoila M; Goldman D
Genomics; 1995 May; 27(2):274-9. PubMed ID: 7557992
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms.
Fentress HM; Grinde E; Mazurkiewicz JE; Backstrom JR; Herrick-Davis K; Sanders-Bush E
Pharmacogenomics J; 2005; 5(4):244-54. PubMed ID: 15912142
[TBL] [Abstract][Full Text] [Related]
4. Serotonin 5-HT
Land MA; Chapman HL; Davis-Reyes BD; Felsing DE; Allen JA; Moeller FG; Elferink LA; Cunningham KA; Anastasio NC
Sci Rep; 2019 Nov; 9(1):16737. PubMed ID: 31723224
[TBL] [Abstract][Full Text] [Related]
5. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging and 5-HT2C receptor polymorphism: a HMPAO-SPECT study in healthy male probands using mCPP-challenge of the 5-HT2C receptor.
Kühn KU; Joe AY; Meyer K; Reichmann K; Maier W; Rao ML; Reinhardt MJ; Biersack HJ; Quednow BB
Pharmacopsychiatry; 2004 Nov; 37(6):286-91. PubMed ID: 15551195
[TBL] [Abstract][Full Text] [Related]
7. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
Herrick-Davis K; Grinde E; Teitler M
J Pharmacol Exp Ther; 2000 Oct; 295(1):226-32. PubMed ID: 10991983
[TBL] [Abstract][Full Text] [Related]
8. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
Popp J; Leucht S; Heres S; Steimer W
Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
[TBL] [Abstract][Full Text] [Related]
9. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction.
Chanrion B; Mannoury la Cour C; Gavarini S; Seimandi M; Vincent L; Pujol JF; Bockaert J; Marin P; Millan MJ
Mol Pharmacol; 2008 Mar; 73(3):748-57. PubMed ID: 18083778
[TBL] [Abstract][Full Text] [Related]
10. A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling.
Berg KA; Dunlop J; Sanchez T; Silva M; Clarke WP
J Pharmacol Exp Ther; 2008 Mar; 324(3):1084-92. PubMed ID: 18065501
[TBL] [Abstract][Full Text] [Related]
11. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice.
Fletcher PJ; Tampakeras M; Sinyard J; Slassi A; Isaac M; Higgins GA
Neuropharmacology; 2009 Sep; 57(3):259-67. PubMed ID: 19501602
[TBL] [Abstract][Full Text] [Related]
13. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
14. Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
Purohit A; Herrick-Davis K; Teitler M
Synapse; 2003 Mar; 47(3):218-24. PubMed ID: 12494404
[TBL] [Abstract][Full Text] [Related]
15. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis analysis of the serotonin 5-HT2C receptor and a Caenorhabditis elegans 5-HT2 homologue: conserved residues of helix 4 and helix 7 contribute to agonist-dependent activation of 5-HT2 receptors.
Xie J; Dernovici S; Ribeiro P
J Neurochem; 2005 Jan; 92(2):375-87. PubMed ID: 15663485
[TBL] [Abstract][Full Text] [Related]
17. WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity.
Dunlop J; Sabb AL; Mazandarani H; Zhang J; Kalgaonker S; Shukhina E; Sukoff S; Vogel RL; Stack G; Schechter L; Harrison BL; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 2005 May; 313(2):862-9. PubMed ID: 15705738
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2C receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity.
Hill MJ; Reynolds GP
Brain Res; 2007 May; 1149():14-7. PubMed ID: 17376412
[TBL] [Abstract][Full Text] [Related]
19. Regulation of serotonin 5-HT2C receptors by chronic ligand exposure.
Devlin MG; Smith NJ; Ryan OM; Guida E; Sexton PM; Christopoulos A
Eur J Pharmacol; 2004 Sep; 498(1-3):59-69. PubMed ID: 15363976
[TBL] [Abstract][Full Text] [Related]
20. Effects of mu-CPP and mesulergine on dietary choices in deprived rats: possible mechanisms of their action.
Antonatos S; Galanopoulou P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):112-9. PubMed ID: 16242827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
